Start-Up Previews (5/03)
Executive Summary
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, Nutrigenomics, features profiles of AlphaGenics Inc., NutraGenomics Inc. and WellGen Inc. Plus these Start-Ups across Health Care: Crystalplex Corp., GlycoFi Inc., NDO Surgical Inc. and Serenex Inc.
You may also be interested in...
High-Stakes Meeting With EMA On The Cards For Oncopeptides’ Pepaxto
Oncopeptides is nearing the end of the regulatory review cycle in the EU for its multiple myeloma drug, melphalan flufenamide. The product has had an erratic journey in the US, where it was approved but then withdrawn, and the withdrawal was subsequently rescinded.
Stock Watch: One Acquisition Does Not Make A Biotech M&A Boom
Another blow-out quarter from Pfizer provided the impetus for an acquisition. But the history of recent commercial-stage biotech transactions and the risky nature of all early-stage companies suggest that the floodgates will not burst open.
EU Business News: PharmaSGP Makes Record Start, BioGaia Heads To Canada, Ardian Takes Nutripure Stake
Round-up of European consumer health business news: Germany's PharmaSGP breaks sales record in Q1 as acquired brands grow; probiotics player BioGaia plans direct distribution in Canada; and private-equity firm Ardian takes a stake in French e-commerce supplements specialist Nutripure.